LAKEFRONT

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 01 Jul 2025 filing date already counts against anyone who files later.

Record

Serial number

99261757

Mark type

Stylized text

Filed

01 Jul 2025

Published for opposition

17 Mar 2026

Attorney of record

Alexandra MacKay

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint disease, inflammatory diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, cancer, hematological cancer, solid tumors, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, dermatomyositis, urticaria, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes; biopharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint disease, inflammatory diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, cancer, hematological cancer, solid tumors, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, dermatomyositis, urticaria, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes
• Class 042 — Scientific and technological services: Medical and scientific research services; industrial research in the field of pharmaceuticals; pharmaceutical and biopharmaceutical research and development services; scientific and medical research services in the nature of examining and testing of genes; pharmaceutical and biopharmaceutical drug development services featuring the, examination and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; pharmaceutical drug development services featuring the, examination and testing of medicaments; product research and development in the field of test systems for pharmaceutical and biopharmaceutical products; database development services, namely, configuration and customization of computer databases containing information regarding medical, pharmaceutical and biopharmaceutical information; pharmaceutical drug development services
• Class 044 — Medical, beauty and agricultural services: Medical services; Medical advisory services; Medical and pharmaceutical consultation; Pharmaceutical advice

Owner

• Galapagos NV, Mechelen, BE
• Galapagos NV, Mechelen, BE

Prosecution history

• 17 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 17 Mar 2026 — PUBLISHED FOR OPPOSITION
• 11 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 19 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 19 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 18 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 18 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 19 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 19 Nov 2025 — NON-FINAL ACTION E-MAILED
• 19 Nov 2025 — NON-FINAL ACTION WRITTEN
• 19 Nov 2025 — ASSIGNED TO EXAMINER
• 01 Jul 2025 — APPLICATION FILING RECEIPT MAILED
• 01 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 01 Jul 2025 — NEW APPLICATION ENTERED